<code id='21305EAEBF'></code><style id='21305EAEBF'></style>
    • <acronym id='21305EAEBF'></acronym>
      <center id='21305EAEBF'><center id='21305EAEBF'><tfoot id='21305EAEBF'></tfoot></center><abbr id='21305EAEBF'><dir id='21305EAEBF'><tfoot id='21305EAEBF'></tfoot><noframes id='21305EAEBF'>

    • <optgroup id='21305EAEBF'><strike id='21305EAEBF'><sup id='21305EAEBF'></sup></strike><code id='21305EAEBF'></code></optgroup>
        1. <b id='21305EAEBF'><label id='21305EAEBF'><select id='21305EAEBF'><dt id='21305EAEBF'><span id='21305EAEBF'></span></dt></select></label></b><u id='21305EAEBF'></u>
          <i id='21305EAEBF'><strike id='21305EAEBF'><tt id='21305EAEBF'><pre id='21305EAEBF'></pre></tt></strike></i>

          fashion

          fashion

          author:leisure time    Page View:4
          Morgan Griffith -- health policy coverage from STAT
          At a Wednesday hearing, Oversight subcommittee Chair Morgan Griffith (R-Va.) mocked Medicare drug price negotiation as “godfather mafia-style negotiation.” Anna Moneymaker/Getty Images

          WASHINGTON — Republicans and Democrats fought it out over Medicare drug price negotiation Wednesday at a House hearing, with the former accusing the latter of setting up “mafia-style” theft of property.

          Typically, intense hearings like the one before the House Energy and Commerce subcommittee take place when lawmakers are debating legislation, not well after a law passes.

          advertisement

          Despite the popularity of Medicare drug price negotiation with voters in both parties, Republicans have attacked the law, known as the Inflation Reduction Act, since Democrats passed it last year. Republicans lawmakers and drugmakers say the drug pricing reforms included in the legislation, which empower Medicare to directly negotiate the prices of some medicines, are tantamount to government price setting and will lead to fewer new drugs. The industry is challenging the program as unconstitutional in multiple courts.

          Get unlimited access to award-winning journalism and exclusive events.

          Subscribe Log In

          focus

          Alkermes shareholders re
          Alkermes shareholders re

          MarkLennihan/APAlkermesshareholdersvotedThursdaytore-electallofthedrugmaker’scurrentdirectors,ending

          read more
          Virtual Event: March of the Biosimilars
          Virtual Event: March of the Biosimilars

          Editor’snote:Arecordingoftheeventisembeddedbelow.SeveralbiosimilarversionsofHumira,whichforyearshasb

          read more
          Medicare proposal to cover medical devices draws a mixed reaction
          Medicare proposal to cover medical devices draws a mixed reaction

          AdobeThemedicaldeviceindustryissplitonwhetheraproposednewMedicarereimbursementpathwaywilldoanythingt

          read more

          U.K. not yet recommending Vertex's CRISPR therapy for sickle cell

          JOSEPHPREZIOSO/AFPviaGettyImagesLONDON—TheU.K.’scost-effectivenesswatchdogsaidThursdayitisnotyetreco